First‐trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell‐free DNA testing-Reference-Cited by-同舟云学术

First‐trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell‐free DNA testing

Published:2014-11-28 Issue:1 Volume:45 Page:42-47
ISSN:0960-7692
Container-title:Ultrasound in Obstetrics & Gynecology
language:en
Short-container-title:Ultrasound Obstet Gynecol

Author:

Kagan K. O.¹,Wright D.²,Nicolaides K. H.³

Affiliation:

1. Department of Obstetrics and GynecologyUniversity of Tuebingen Tuebingen Germany

2. Institute of Health ResearchUniversity of Exeter Exeter UK

3. Harris Birthright Research Centre for Fetal MedicineKing's College Hospital London UK

Publisher

Wiley

Subject

Obstetrics and Gynaecology,Radiology Nuclear Medicine and imaging,Reproductive Medicine,General Medicine,Radiological and Ultrasound Technology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/uog.14691

Reference23 articles.

1. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A

2. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation

3. Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11 + 0 to 13 + 6 weeks of gestation

4. Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation

5. A Mixture Model of Ductus Venosus Pulsatility Index in Screening for Aneuploidies at 11–13 Weeks’ Gestation

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The ‘Radiant Effect’: Recent Sonographic Image-Enhancing Technique and Its Impact on Nuchal Translucency Measurements;Journal of Clinical Medicine;2024-06-20

2. Maternal Reassurance, Satisfaction, and Anxiety after First-Trimester Screening for Aneuploidies: Comparison between Contingent Screening and Universal Cell-Free DNA Testing;Diagnostics;2024-06-06

3. The Relation of Ductus Venosus Pulsatility Index and Nuchal Translucency Thickness in a First-Trimester Sonographic Examination: A Matched Case-Control Study;Journal of Diagnostic Medical Sonography;2024-02-07

4. Ersttrimester-Klinik zum Zeitpunkt 11–13+6 Schwangerschaftswochen: Screening, Risikoberechnung und Management;Springer Reference Medizin;2024

5. Ersttrimester-Klinik zum Zeitpunkt 11–13+6 Schwangerschaftswochen: Screening, Risikoberechnung und Management;Springer Reference Medizin;2024